Barclays Raises CME Group (NASDAQ:CME) Price Target to $219.00

CME Group (NASDAQ:CMEFree Report) had its target price increased by Barclays from $209.00 to $219.00 in a report published on Monday morning, Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock.

A number of other brokerages also recently issued reports on CME. Bank of America upped their price objective on CME Group from $177.00 to $180.00 and gave the company an underperform rating in a research note on Thursday, October 3rd. TD Cowen started coverage on CME Group in a research note on Thursday, September 26th. They issued a hold rating and a $221.00 target price on the stock. Royal Bank of Canada reissued a sector perform rating and set a $235.00 price objective on shares of CME Group in a report on Thursday, October 3rd. Keefe, Bruyette & Woods lifted their price objective on CME Group from $212.00 to $213.00 and gave the stock a market perform rating in a research report on Thursday, July 25th. Finally, The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the stock a sell rating in a report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of Hold and an average target price of $217.71.

Read Our Latest Stock Report on CME Group

CME Group Trading Down 0.1 %

CME stock opened at $221.25 on Monday. The company has a market capitalization of $79.66 billion, a PE ratio of 25.14, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. CME Group has a 52 week low of $190.70 and a 52 week high of $226.78. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The company’s 50-day simple moving average is $213.67 and its 200 day simple moving average is $207.83.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue was up 12.7% compared to the same quarter last year. During the same period last year, the company earned $2.30 EPS. As a group, sell-side analysts anticipate that CME Group will post 9.94 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Several hedge funds and other institutional investors have recently made changes to their positions in CME. Capital International Investors boosted its holdings in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. grew its position in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after acquiring an additional 1,309,097 shares in the last quarter. M&G Plc purchased a new position in CME Group in the first quarter valued at about $156,631,000. Assenagon Asset Management S.A. lifted its position in shares of CME Group by 577.9% during the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after purchasing an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.